ATIM-36. DOSE ESCALATION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG)
Published
Conference Paper
Full Text
Cited Authors
- Desjardins, A; Randazzo, D; Chandramohan, V; Peters, K; Johnson, M; Thomas, L; Threatt, S; Bullock, C; Herndon, J; Boulton, S; Healy, P; Lipp, E; Sampson, J; Friedman, A; Friedman, H; Ashley, D; Bigner, D
Duke Contributors
Published Date
- November 5, 2018
Published In
Volume / Issue
- 20 / suppl_6
Start / End Page
- vi9 - vi9
Published By
Electronic International Standard Serial Number (EISSN)
- 1523-5866
International Standard Serial Number (ISSN)
- 1522-8517
Digital Object Identifier (DOI)
- 10.1093/neuonc/noy148.031
Conference Name
- 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
Conference Location
- New Orleans, LA
Conference Start Date
- November 15, 2018
Conference End Date
- November 18, 2018